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Carefully chosen peptide systems can provide valuable insights
into the details of protein folding. Construction of the secon-
dary structures most commonly observed in proteins, namely
a-helices and b-sheets, from constrained amino acid residues
allows detailed investigation of the factors driving the folding
and stability of these structural scaffolds.[1] Structure formation
in these cases is driven largely by local nonbonded interactions
and backbone hydrogen bonding. Helix design by incorpora-
tion of constrained amino acids such as Aib (U, a-aminoisobu-
tyric acid) and its analogues has achieved great success.[2] Early
studies of b-hairpin design by using sequences derived from
proteins did not yield well-folded structures.[3] Subsequently,
hairpin design has been effectively achieved with the use of D-
Pro-Xxx sequences as turn nucleators in synthetic oligopep-
tides. D-Pro-Xxx segments favor the formation of type II’/I’ b-
turns, which in turn promote hairpin registry.[4] The role of ter-
tiary (side chain–side chain) interactions that are predominant
in protein interiors can now be probed by specifically position-
ing appropriate residues at desired sites in peptides with pre-
defined structures. Specific aromatic–aromatic interactions
have been suggested to be important in stabilizing hairpin
structures in aqueous solutions.[5] Study of aromatic interac-
tions also gains significance in the light of b-sheet aggregation,
which leads to the formation of amyloids and results in protein
aggregation and neurodegenerative diseases.[6]
As part of a program to explore aromatic interactions be-
tween side chains appropriately positioned on helical and hair-
pin scaffolds, we have investigated a series of designed pep-
tides rich in aromatic residues. A prerequisite to the unambigu-
ous characterization of the backbone conformation from spec-
troscopic data rests in the ability of those data to uniquely
relate to the conformation. Electronic Circular Dichroism (ECD),
which often provides a quick method to assess the conforma-
tion of a designed peptide, is usually inapplicable in the case
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of sequences rich in aromatic residues because of the exten-
sive absorption of aromatic chromophores in the far-UV
region. NMR spectroscopy is the method of choice for estab-
lishing solution conformation, but can prove time consuming
if a large number of peptides are to be investigated. Vibration-
al Circular Dichroism (VCD) is developing into a powerful tech-
nique for peptide conformation analysis,[7] providing an attrac-
tive alternative to ECD for peptides with aromatic chromo-
phores.[8] VCD is based on the chiral perturbation of a vibra-
tional transition and measures the difference in the absorbance
of left and right circularly polarized light in the infrared
region.[7,9] VCD studies have recently been applied to the con-
formation analysis of peptides with the specific intention of
identifying secondary structures like helices and sheets. Several
groups have developed VCD applications for the characteriza-
tion of helices.[7, 10] Previous studies have described the use of
VCD methods in providing a diagnostic of b-hairpin conforma-
tions.[8, 11] In this paper, we examine model peptide helices and
b-hairpins rich in tryptophan and tyrosine residues (Table 1)
and demonstrate that VCD spectroscopy provides a clear diag-
nostic of backbone structure in cases for which ECD spectra
are completely anomalous.
Peptides 1–6 were designed to form b-hairpins by placing a
D-Pro-Gly segment at the center of the sequence. Peptides 2–5
formed well-defined hairpins with type II’ turns in organic sol-
vents (Table 1), as determined by 2D NMR spectroscopy (see
Supporting Information for a summary of unpublished NMR re-
sults). Peptide 6 appeared to form a frayed hairpin structure
with a type I’ b-turn. This is presumably because of the bulky
Trp residues at positions adjacent to the central b-turn; these
might result in interactions between the indole ring and flank-
ing amide bonds that, in turn, influence local conformation.[12]
The far-UV ECD spectra of peptides 1–6 in methanol are
shown in Figure 1A and B. Peptide hairpins are generally char-
acterized by a broad, negative ECD band at ~218 nm. Inspec-
tion of the spectra in Figure 1A and B clearly reveals several
features that may be attributed to contributions from the aro-
matic chromophores, giving rise to anomalous far-UV ECD
spectra. The positioning of the aromatic residues influences
the interactions between the side chains. For example, in an
ideal hairpin, strong cross-strand interactions may be anticipat-
ed when aromatic residues are placed at positions 2 and 7 in
octapeptide segments.[8, 13] Figure 2A and B illustrates the ob-
served aromatic-proton chemical shifts for the Tyr residue at
positions 2 and 7 in peptide 3. A remarkable upfield shift is ob-
served for the Tyr7 CdH proton due to shielding by the ring
currents of the facing Tyr2 residue. The temperature depend-
ence means that the effect is substantially more pronounced
at low temperatures, at which side-chain conformational ex-
change is limited. Aromatic interactions are also anticipated for
residue pairs 1–3 and 6–8 along the strand segments, as well
as 1–6 and 3–8 diagonally across the two strands of the hair-
pin. Strong aromatic interactions therefore contribute to the
far-UV ECD spectra observed for the peptides studied, making
unambiguous structural characterization difficult.
Peptides 7–10b form predominantly helical conformations
in chloroform (Table 1), as determined by NMR methods (un-
published NMR data, see Supporting Information). ROESY spec-
tra of the helical peptides carried out in CDCl3 revealed the
presence of almost all sequential dNN NOEs. In addition, we ob-
tained medium-to-weak i–i+2 and i–i+3 daN NOEs; this sug-
gests that the peptides adopted a 310-helical conformation in
solution (unpublished). This observation is not surprising, as
several Aib-containing short synthetic peptides are shown to
adopt a 310-helical conformation in crystals.
[14] However, the
possibility of facile exchange between the 310- and a-helical
conformations must always be considered. Indeed, mixed heli-
cal structures are frequently observed in the solid state for hy-
drophobic helical sequences.[15] Peptide 10a contains a D-Val
residue at position 3, which may be expected to perturb the
Table 1. Peptide sequences, mass spectral data, conformations, and VCD data.
No. Sequence[a] Mass [Da] Solution VCD band
[M+Na]+ [M+K]+ Mcalc Conformation
[b] positions [cm1][c]
1 Boc-LWVDPGLLV-OMe 1031.8 1047.8 1009 b-hairpin () 1658
2 Boc-WLVDPGWLV-OMe 1105.9 1122.1 1083 b-hairpin () 1649
3 Ac-LYVDPGLYV-OMe 1000.6 1016.8 978 b-hairpin () 1649
4 Boc-YLVDPGWLV-OMe 1081.6 1097.6 1059 b-hairpin () 1651
5 Boc-LLVDPGYLW-OMe 1095.7 1111.8 1073 b-hairpin () 1648
6 Boc-WLWDPGWLW-OMe 1277.8 1293.9 1256 b-hairpin () 1653
7 Boc-WLWUWLW-OMe 1208.7 1224.6 1187 helix () 1678, (+) 1651
8 Boc-UWLWUWLW-OMe 1297.4 1312.9 1273 helix () 1674, (+) 1654
9 Boc-LWVAULWV-OMe 1108.6 1124.5 1084 helix () 1672, (+) 1652
10a Boc-LWDVUAULWV-OMe 1193.5 1209.6 1169 helix () 1672, (+) 1650
10b Boc-LWVUAULWV-OMe 1193.7 1209.8 1169 helix () 1670, (+) 1650
11 Boc-WLWUGWLW-OMe 1267.2 1283.9 1244 helix () 1674, (+) 1654
[a] In the peptide sequence, DP=D-Pro and U=Aib. [b] The solution conformations of all peptides were inferred from NMR data (Bruker DRX 500 MHz NMR
spectrometer; all spectra recorded at 303 K) in CDCl3 for peptides 7–10b, in CDCl3 + 10% [D6]DMSO for peptides 1–6, and additionally in CD3OH for pep-
tide 3. Chemical-shift dispersion of backbone NH and CaH resonances as well as 3JNH–C
a
H coupling constants were used as diagnostics. b-Hairpins yielded a
large chemical-shift dispersion and high (>7.5) 3JNH–C
a
H values, while helices had limited chemical-shift dispersion and small
3JNH–C
a
H values (6). NOEs were
used to confirm conformational assignments. Helices yielded a succession of NiHNi+1H (dNN) NOEs, while b-hairpins were characterized by the observation
of cross-strand NHNH (1–8, 3–6) and CaHCaH NOEs (residues 2–7; unpublished data). Complete NMR analysis was carried out for all peptides except 1
and 11, for which structural information is based on chemical-shift dispersion and 3JNa coupling constants. [c] VCD spectra were recorded in CDCl3.
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helical conformation at the N terminus. Evidence from NMR ex-
periments, however, clearly demonstrates that the overall con-
formation of the peptide is a helix in solution, with a local dis-
tortion in the backbone near the D-amino acid (see Supporting
Information). It should be noted that D residues can indeed be
comfortably accommodated in right-handed-helix structures,
as demonstrated by recent crystal structures of synthetic pep-
tides containing multiple D residues placed in host L-amino
acid sequences.[16] Peptide 11 contains a central Aib-Gly seg-
ment, which, in principle, can adopt either a type I/III or
type I’/III’ b-turn conformation. A helical fold of the octapep-
tide would be supported by type I/III stereochemistry, while a
hairpin may be formed with a type I’/III’ conformation. The far-
UV ECD spectra of peptides 7–11 are illustrated in Figure 1C
and D. ECD spectra of helices are generally characterized by
negative bands at ~222 and ~208 nm as well as a positive
band at ~195 nm. In short helical peptides, which consist of
up to 3–4 turns of 310- or a-helices, the relative intensities of
the two minima can be significantly different, with the n–p*
band at 222 nm exhibiting diminished ellipticity.[15,17] Inspec-
tion of the spectra in Figure 1C and D reveals anomalous fea-
tures, specifically, the positive band at ~225–230 nm in pep-
tides 7, 8, 10a, and 11. Of the six peptides listed, only two (9
and 10b) yield spectra that resemble those anticipated for
short helices.
The far-UV ECD data for the peptides examined in this study
suggest that, for both helices and b-hairpins, anomalous far-UV
ECD spectra are obtained when the sequence contains one or
more Trp/Tyr residues. In the sequences studied, through-
space interactions may be expected in a hairpin conformation
for peptides 1–6. In the case of the helices, aromatic interac-
tions may be expected when the residues are placed at posi-
tions i/i+3 or i/i+4. This condition is satisfied in sequences 7, 8
and 11. In helical structures, variations of the side-chain torsion
angles can result in multiple orientations of the projecting aro-
matic groups, which generally preclude close interactions, such
as those observed across antiparallel strands in a hairpin struc-
ture. The aromatic chromophores can, however, be sufficiently
proximal[18] to contribute to the far-UV ECD spectra, thereby
masking transitions of the backbone. Aromatic–amide interac-
tions, observed in several Trp-containing peptides,[12] cause ad-
ditional absorption effects and complicate the ECD spectrum.
The data presented in Figure 1 clearly demonstrate that far-UV
ECD does not provide reliable information on peptide confor-
mation when multiple aromatic residues are present. In sharp
contrast, VCD spectra provide an unambiguous distinction be-
tween the two groups of peptides.
Table 1 as well as Figures 3 and 4 summarize the VCD spec-
tra in the region of the amide I band for peptides 1–6 and 7–
11. It should be mentioned that although the VCD spectra
Figure 1. Far-UV ECD spectra of peptide hairpins (A and B) and helices (C and D) recorded in methanol at an ambient temperature of ~298 K. Plot of total
molar ellipticities ([q]M /degcm
2dmol1) as a function of wavelength. A) Peptide 1: Boc-LWVDPGLLV-OMe, peptide 2 : Boc-WLVDPGWLV-OMe, peptide 3 : Ac-
LYVDPGLYV-OMe; B) peptide 4 : Boc-YLVDPGWLV-OMe, peptide 5 : Boc-LLVDPGYLW-OMe, peptide 6 : Boc-WLWDPGWLW-OMe; C) peptide 7: Boc-WLWUWLW-OMe,
peptide 8 : Boc-UWLWUWLW-OMe, peptide 9 : Boc-LWVAULWV-OMe; D) peptide 10a : Boc-LWDVUAULWV-OMe, peptide 10b : Boc-LWVUAULWV-OMe, peptide
11: Boc-WLWUGWLW-OMe (DP=D-Pro; U=Aib).
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were recorded in CDCl3, the ECD spectra were obtained in
methanol, as strong chloroform absorption bands hamper the
acquisition of far-UV ECD spectra. However, independent struc-
tural information in CDCl3 was obtained for most of the pep-
tides by using solution NMR methods (some peptide hairpins
that showed broad backbone resonances in chloroform at the
concentrations used for NMR experiments were recorded in
CDCl3 + 10% [D6]DMSO; see Supporting Information) and are
listed in Table 1. Additionally, 2D NMR experiments were re-
peated in CD3OH for one of the peptides (peptide 3), and the
chloroform structure was found to be essentially maintained in
this case. For this peptide, VCD spectra were recorded in both
chloroform and in CH3OD.
All the hairpin-forming sequences show a negative VCD
band at ~1648–1660 cm1 (Figure 3), which is associated with
a strong IR absorption band, in chloroform. As proposed earli-
er,[8] this strong absorption band and the associated negative
VCD band are thought to originate from b-strands. The spec-
trum of peptide 3 in methanol (Figure 2C) shows a negative
VCD band at 1641 cm1 accompanied by a broad IR-absorption
band centered at 1649 cm1. The observed VCD bands in
CH3OD are shifted to lower frequencies as compared to chloro-
form (1649 cm1). The origin of this shift could be due to sol-
vent polarity and/or H–D exchange, which will influence
amide I band positions. The helices, peptides 7–11, reveal a
couplet with a positive component at ~1650–1654 cm1 and a
negative component at ~1670–1678 cm1 (Figure 4), which is
characteristic of a right-handed helical structure. VCD spectra
of helical peptides 7 and 8 also showed a positive band at
~1720 cm1, which might be associated with the carbonyl
Figure 3. Vibrational absorption (bottom) and VCD (top; DAK106) spectra of peptide hairpins recorded in deuterated chloroform at 293 K. A) Peptide 1: Boc-
LWVDPGLLV-OMe); B) peptide 2 : Boc-WLVDPGWLV-OMe); C) peptide 3 : Ac-LYVDPGLYV-OMe; D) peptide 4 : Boc-YLVDPGWLV-OMe); E) peptide 5 : Boc-LLVDPGYLW-
OMe; F) peptide 6 : Boc-WLWDPGWLW-OMe (DP= D-Pro; U=Aib).
Figure 2. A) Chemical-shift dependence of the aromatic-ring-proton resonan-
ces as a function of temperature. Spectra recorded on a Bruker DRX
500 MHz spectrometer with sample concentrations of ~10 mM in CD3OH.
Note the anomalous upfield shift of the Tyr7 CdH protons (meta to the phe-
nolic hydroxyl group). B) Plot of the chemical-shift variation of the aromatic
resonances in peptide 3 with temperature. C) Vibrational absorption (bot-
tom) and VCD (top; DAK106) spectra of peptide 3 in methanol. A negative
band at 1641 cm1, characteristic of b-hairpins, is observed.
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moiety of the tert-butyloxycarbonyl (Boc) group. The urethane
band is seen only in the case of the helical peptides containing
four Trp residues; however, with the present data, we find it
difficult to explain why this observation is restricted to 7 and
8. In the case of peptide 10a, it was interesting to note that
despite the presence of a D-amino acid in the sequence, which,
in principle, should act as a helix breaker, a characteristic VCD
spectrum for a helix is obtained. As mentioned earlier, NMR
studies in CDCl3 support the results obtained from the VCD
spectrum of this peptide. It is clear from NMR experiments (see
Supporting Information) that although there is a local distor-
tion in the helical scaffold, the D-amino acid is largely accom-
modated in a right-handed helix. Likewise, the VCD spectrum
of this peptide also clearly indicates the presence of a negative
band at ~1672 cm1 and a positive band at ~1650 cm1. We
therefore conclude that the presence of a D-amino acid does
not necessarily disrupt the overall helical scaffold in all cases,
as was demonstrated earlier.[16]
There is a clear distinction between the VCD spectra ob-
tained for the groups of peptide hairpins and helices. Peptide
11, which can, in principle, adopt either a helical or hairpin
conformation, shows clear evidence for the formation of a
helix in the VCD spectrum. In previous studies from the labora-
tory, the sequence Boc-LVVUGLVV-OMe was investigated, and
NMR studies support a solvent-dependent helix-to-hairpin tran-
sition, forming a helix in non-hydrogen-bonding solvents like
chloroform and acetonitrile and adopting a b-hairpin confor-
mation in hydrogen-bonding solvents like methanol and di-
methyl sulfoxide.[19] Such solvent-dependent structural transi-
tions can now be easily characterized by using VCD spectros-
copy in cases such as peptide 11, in which aromatic interac-
tions obscure peptide transitions in the far-UV ECD spectrum.
The peptides investigated in the present study have been
designed in order to populate a specific ordered conformation,
either a hairpin or a helix. In the sequences that are rich in aro-
matic residues, VCD has provided clearly identifiable finger-
prints in the amide I region for the two kinds of peptide secon-
dary structures examined. Independent evidence for the
nature of the preferred conformations obtained from NMR
studies (unpublished) correlates well with the VCD data. The
use of well-defined model peptides therefore permits the de-
velopment of VCD methods as a tool in peptide- and protein-
conformation analysis.
Experimental Section
Peptide synthesis: All peptides were synthesized by conventional
solution-phase chemistry by using fragment-condensation strategy.
The Boc group was used for N-terminal protection and the C termi-
nus was blocked as the methyl ester. For peptide 3, the acetyl
group was employed for N-terminal protection. Deprotection of
the Boc- and -OMe groups was carried out by using 98% formic
acid and alcoholic NaOH, respectively. Couplings were mediated
by using dicyclohexylcarbodiimide/1-hydroxybenzotriazole (DCC/
HOBt). Some of the intermediates were characterized on a TLC
plate (silica gel), by 1D 1H NMR (80 MHz) spectroscopy as well as
ESI-MS mass spectrometry and used without further purification.
Figure 4. Vibrational absorption (bottom) and VCD (top; DAK106) spectra of peptide helices recorded in deuterated chloroform at 293 K. A) peptide 7: Boc-
WLWUWLW-OMe; B) peptide 8 : Boc-UWLWUWLW-OMe; C) peptide 9 : Boc-LWVAULWV-OMe; D) peptide 10a : Boc-LWDVUAULWV-OMe; E) peptide 10b : Boc-
LWVUAULWV-OMe; F) peptide 11: Boc-WLWUGWLW-OMe (DV=D-Val; U=Aib).
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The final peptides were purified by medium-pressure liquid chro-
matography (MPLC; C18, 40–60 mm) and, wherever required, by
high-performance liquid chromatography (HPLC; C18, 5–10 mm,
10K250 mm) with methanol/water gradients. During the synthesis
of peptide 10, the coupling of the 1–3 fragment (Boc-LWV-OH) to
the 4–9 fragment (H2N-UAULWV-OMe; U=Aib, a-aminoisobutyric
acid) yielded two peptides (10a and 10b) that had identical mass
spectra but were separable by MPLC. Analysis of the 500 MHz NMR
spectra (1D 1H, 2D ROESY, DMSO titration experiments) clearly es-
tablished that the two nonapeptides differed in the configuration
of V3, racemization having occurred during the activation of the
tripeptide. The Val-Aib coupling is known to be difficult and is a
slow reaction often resulting in racemization in couplings involving
activation of a Val carboxylic acid group, despite the use of racemi-
zation-suppressing additives (unpublished results). Racemization
was encountered only in the case of peptide 10.
MALDI-TOF mass spectrometry: Mass spectra of the purified pep-
tides were recorded on a Kompaq Seq MALDI-TOF mass spectrom-
eter (Kratos Analytical, Manchester, UK). Complete characterizations
of all the peptides except peptides 1 and 11 were carried out by
2D 1H NMR (500 MHz) spectroscopy (unpublished results). Table 1
lists peptides studied along with data obtained from mass spec-
trometry studies.
Electronic circular dichroism: Far-UV ECD spectra were recorded
on a JASCO J-715 spectropolarimeter with methanol as the solvent.
Calibration of the instrument was done by using d-(+)-10-cam-
phorsulfonic acid. A path length of 1 mm for far-UV was employed.
Data were acquired in the wavelength-scan mode by using a 1 nm
bandwidth with a step size of 0.2 nm and a scan speed of
20 nmmin1. Typically, five scans were acquired, and the data were
averaged. Solvent subtraction was carried out by using methanol
as a blank, and the spectra were smoothed.
Vibrational circular dichroism: All VCD spectra were recorded on
a commercial Chiralir spectrometer (BomemBiotools, QuNbec,
Canada). The peptide (2 mg) was dissolved in CDCl3 (200 mL), and
the spectra were recorded in a fixed-path-length (100 mm) cell at
293 K. All spectra were collected for 1 h at a resolution of 8 cm1,
and solvent contribution was subtracted.
Acknowledgements
R.M. is supported by the award of a Senior Research Fellowship
from the Council of Scientific and Industrial Research, India. This
work was supported by the program of Drug and Molecular
Design, Department of Biotechnology, India, and by the National
Science Foundation (CHE0092922).
Keywords: aromatic compounds · circular dichroism · hairpin
peptides · helical structures · peptides
[1] a) S. H. Gellman, Curr. Opin. Chem. Biol. 1998, 2, 717–725; b) D. J. Hill,
M. J. Mio, R. B. Prince, T. S. Hughes, J. S. Moore, Chem. Rev. 2001, 101,
3893–4012; c) J. Venkatraman, S. C. Shankaramma, P. Balaram, Chem.
Rev. 2001, 101, 3131–3152; d) S. Aravinda, N. Shamala, R. S. Roy, P.
Balaram, Proc. Indian Acad. Sci. Chem. Sci. 2003, 115, 373–400.
[2] a) B. V. Prasad, P. Balaram, CRC Crit. Rev. Biochem. 1984, 16, 307–348;
b) C. Toniolo, E. Benedetti, ISI Atlas Sci. Biochem. 1988, 1, 225–230; c) E.
Benedetti, Biopolymers 1996, 40, 3–44; d) R. Kaul, P. Balaram, Bioorg.
Med. Chem. 1999, 7, 105–117.
[3] a) F. J. Blanco, M. A. Jiminez, M. Rico, J. Santoro, J. Herranz, J. L. Nieto,
Eur. J. Biochem. 1991, 200, 345–351; b) F. J. Blanco, M. A. Jiminez, J.
Herranz, M. Rico, J. Santoro, J. L. Nieto, J. Am. Chem. Soc. 1993, 115,
5887–5888.
[4] a) S. K. Awasthi, S. Raghothama, P. Balaram, Biochem. Biophys. Res.
Commun. 1995, 216, 375–381; b) I. L. Karle, S. K. Awasthi, P. Balaram,
Proc. Natl. Acad. Sci. USA 1996, 93, 8189–8193; c) T. S. Haque, S. H. Gell-
man, J. Am. Chem. Soc. 1997, 119, 2303–2304; d) S. Raghothama, S. K.
Awasthi, P. Balaram, J. Chem. Soc. Perkin Trans. 2 1998, 137–143; e) H. E.
Stanger, S. H. Gellman, J. Am. Chem. Soc. 1998, 120, 4236–4237; f) J. F.
Espinosa, S. H. Gellman, Angew. Chem. 2000, 112, 2420-2423; Angew.
Chem. Int. Ed. 2000, 39, 2330–2333; g) C. Das, G. A. Naganagowda, I. L.
Karle, P. Balaram, Biopolymers 2001, 58, 335–346.
[5] a) A. G. Cochran, N. J. Skelton, M. A. Starovasnik, Proc. Natl. Acad. Sci.
USA 2001, 98, 5578–5583; b) C. D. Tatko, M. L. Waters, J. Am. Chem. Soc.
2002, 124, 9372–9373; c) M. L. Waters, Curr. Opin. Chem. Biol. 2002, 6,
736–741; d) M. L. Waters, Biopolymers 2004, 76, 435–445.
[6] a) E. Gazit, FASEB J. 2002, 16, 77–83; b) S. M. Tracz, A. Abedini, M. Dris-
coll, D. P. Raleigh, Biochemistry 2004, 43, 15901–15908.
[7] a) B. B. Lal, L. A. Nafie, Biopolymers 1982, 21, 2161–2183; b) A. C. Sen,
T. A. Keiderling, Biopolymers 1984, 23, 1533–1545; c) E. D. Lipp, L. A.
Nafie, Biopolymers 1985, 24, 799–812; d) S. C. Yasui, T. A. Keiderling,
G. M. Bonora, C. Toniolo, Biopolymers 1986, 25, 79–89; e) S. C. Yasui,
T. A. Keiderling, Biopolymers 1986, 25, 5–15; f) P. Pancoska, S. C. Yasui,
T. A. Keiderling, Biochemistry 1989, 28, 5917–5923; g) P. Pancoska, L.
Wang, T. A. Keiderling, Protein Sci. 1993, 2, 411–419; h) L. A. Nafie, T. B.
Freedman, Enantiomer 1998, 3, 283–297; i) C. Zhao, P. L. Polavarapu,
Biospectroscopy 1999, 5, 276–283; j) C. Zhao, P. L. Polavarapu, J. Am.
Chem. Soc. 1999, 121, 11259–11260; k) C. Zhao, P. L. Polavarapu, Bio-
polymers 2001, 62, 336–340; l) A. Boricks, R. F. Murphy, S. Lovas, Bio-
polymers 2003, 72, 21–24; m) J. P. Mazaleyrat, K. Wright, A. Gaucher, N.
Toulemonde, M. Wakselman, S. Oancea, C. Peggion, F. Formaggio, V.
Setnicka, T. A. Keiderling, C. Toniolo, J. Am. Chem. Soc. 2004, 126,
12874–12879.
[8] C. Zhao, P. L. Polavarapu, C. Das, P. Balaram, J. Am. Chem. Soc. 2000,
122, 8228–8231.
[9] a) U. Narayanan, T. A. Keiderling, G. M. Bonora, C. Toniolo, Biopolymers
1985, 24, 1257–1263; b) W. M. Zuk, T. B. Freedman, L. A. Nafie, Biopoly-
mers 1989, 28, 2025–2044; c) P. Pancoska, S. C. Yasui, T. A. Keiderling,
Biochemistry 1991, 30, 5089–5103; d) P. Pancoska, T. A. Keiderling, Bio-
chemistry 1991, 30, 6885–6895; e) T. A. Keiderling, Curr. Opin. Chem.
Biol. 2002, 6, 682–688.
[10] a) G. Yoder, A. Polese, R. A. G. D. Silva, F. Formaggio, M. Crisma, Q. B.
Broxterman, J. Kamphuis, C. Toniolo, T. A. Keiderling, J. Am. Chem. Soc.
1997, 119, 10278–10285; b) T. A. Keiderling, R. A. G. D. Silva, G. Yoder,
R. K. Dukor, Bioorg. Med. Chem. 1999, 7, 133–141; c) F. Wang, P. L. Pola-
varapu, Biopolymers 2003, 70, 614–619.
[11] a) U. Narayanan, T. A. Keiderling, G. M. Bonora, C. Toniolo, J. Am. Chem.
Soc. 1986, 108, 2431–2437; b) G. Yoder, T. A. Keiderling, F. Formaggio,
M. Crisma, C. Toniolo, Biopolymers 1995, 35, 103–111; c) P. Xie, Q. Zhou,
M. Diem, J. Am. Chem. Soc. 1995, 117, 9502–9508; d) V. Baumruk, P. Pan-
coska, T. A. Keiderling, J. Mol. Biol. 1996, 259, 774–791; e) J. Kubelka,
T. A. Keiderling, J. Am. Chem. Soc. 2001, 123, 12048–12058; f) J. Hilario,
J. Kubelka, F. A. Syud, S. H. Gellman, T. A. Keiderling, Biopolymers 2002,
67, 233–236; g) J. Hilario, J. Kubelka, T. A. Keiderling, J. Am. Chem. Soc.
2003, 125, 7562–7574; h) C. Paul, J. Wang, W. C. Wimley, R. M. Hoch-
strasser, P. H. Axelsen, J. Am. Chem. Soc. 2004, 126, 5843–5850.
[12] A. Sengupta, R. Mahalakshmi, N. Shamala, P. Balaram, J. Pept. Res. 2005,
65, 113–129.
[13] S. Aravinda, N. Shamala, R. Rajkishore, H. N. Gopi, P. Balaram, Angew.
Chem. 2002, 114, 4019–4021; Angew. Chem. Int. Ed. 2002, 41, 3863–
3865.
[14] a) I. L. Karle, P. Balaram, Biochemistry 1990, 29, 6747–6756; b) C. Toniolo,
M. Crisma, G. M. Bonora, E. Benedetti, D. B. Blasio, P. Pavone, C. Pedine,
A. Santini, Biopolymers 1991, 31, 129–138; c) I. L. Karle, J. L. Flippen-
Anderson, R. Gurunath, P. Balaram, Protein Sci. 1994, 3, 1547–1555;
d) S. Mammi, M. Rainaldi, M. Bellanda, E. Schievano, E. Peggion, Q. B.
Broxterman, F. Formaggio, M. Crisma, C. Toniolo, J. Am. Chem. Soc.
2000, 122, 11735–11736.
[15] S. Aravinda, S. Datta, N. Shamala, P. Balaram, Angew. Chem. Int. Ed.
2004, 116, 6896–6899; Angew. Chem. Int. Ed. 2004, 43, 6728–6731.
ChemBioChem 2005, 6, 2152 – 2158 : 2005 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim www.chembiochem.org 2157
[16] a) S. Aravinda, N. Shamala, S. Desiraju, P. Balaram, Chem. Commun.
2002, 2454–2455; b) I. L. Karle, H. N. Gopi, P. Balaram, Proc. Natl. Acad.
Sci. USA 2003, 100, 13946–13951.
[17] a) T. S. Sudha, E. K. S. Vijayakumar, P. Balaram, Int. J. Pept. Protein Res.
1983, 22, 464–468; b) M. C. Manning, R. W. Woody, Biopolymers 1991,
31, 569–586; c) N. H. Anderson, Z. Liu, K. S. Prickett, FEBS. Lett. 1996,
399, 47–52; d) C. Toniolo, A. Polese, F. Formaggio, J. Kamphius, J. Am.
Chem. Soc. 1996, 118, 2744–2745; e) G. Yoder, A. Polese, R. A. G. D.
Silva, F. Formaggio, M. Crisma, Q. B. Broxterman, J. Kamphius, C. Toniolo,
T. A. Keiderling, J. Am. Chem. Soc. 1997, 119, 10278–10285; f) P. Walli-
mann, R. J. Kennedy, D. S. Kemp, Angew. Chem. 1999, 111, 1377–1379;
Angew. Chem. Int. Ed. 1999, 38, 1290–1292; g) P. Wallimann, R. J. Ken-
nedy, J. S. Miller, W. Shalongo, D. S. Kemp, J. Am. Chem. Soc. 2003, 125,
1203–1220.
[18] a) R. Bhattacharyya, U. Samanta, P. Chakrabarti, Protein Eng. 2002, 15,
91–100; b) S. M. Butterfield, P. R. Patel, M. L. Waters, J. Am. Chem. Soc.
2002, 124, 9751–9755; c) S. Aravinda, N. Shamala, C. Das, A. Sriranjini,
I. L. Karle, P. Balaram, J. Am. Chem. Soc. 2003, 125, 5308–5315.
[19] S. K. Awasthi, S. C. Shankaramma, S. Raghothama, P. Balaram, Biopoly-
mers 2001, 58, 465–476.
Received: April 8, 2005
Revised: August 4, 2005
Published online on October 31, 2005
2158 www.chembiochem.org : 2005 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim ChemBioChem 2005, 6, 2152 – 2158
